全文获取类型
收费全文 | 23897篇 |
免费 | 2592篇 |
国内免费 | 527篇 |
专业分类
耳鼻咽喉 | 212篇 |
儿科学 | 480篇 |
妇产科学 | 286篇 |
基础医学 | 2662篇 |
口腔科学 | 505篇 |
临床医学 | 2891篇 |
内科学 | 3457篇 |
皮肤病学 | 177篇 |
神经病学 | 1975篇 |
特种医学 | 1572篇 |
外国民族医学 | 4篇 |
外科学 | 2289篇 |
综合类 | 2772篇 |
现状与发展 | 1篇 |
一般理论 | 2篇 |
预防医学 | 2315篇 |
眼科学 | 450篇 |
药学 | 2629篇 |
35篇 | |
中国医学 | 1107篇 |
肿瘤学 | 1195篇 |
出版年
2023年 | 442篇 |
2022年 | 604篇 |
2021年 | 1068篇 |
2020年 | 1148篇 |
2019年 | 1045篇 |
2018年 | 1105篇 |
2017年 | 1027篇 |
2016年 | 918篇 |
2015年 | 960篇 |
2014年 | 1725篇 |
2013年 | 1650篇 |
2012年 | 1392篇 |
2011年 | 1500篇 |
2010年 | 1269篇 |
2009年 | 1080篇 |
2008年 | 1078篇 |
2007年 | 1061篇 |
2006年 | 999篇 |
2005年 | 771篇 |
2004年 | 708篇 |
2003年 | 595篇 |
2002年 | 558篇 |
2001年 | 385篇 |
2000年 | 344篇 |
1999年 | 328篇 |
1998年 | 246篇 |
1997年 | 206篇 |
1996年 | 184篇 |
1995年 | 187篇 |
1994年 | 193篇 |
1993年 | 149篇 |
1992年 | 154篇 |
1991年 | 152篇 |
1990年 | 153篇 |
1989年 | 143篇 |
1988年 | 133篇 |
1987年 | 105篇 |
1986年 | 98篇 |
1985年 | 135篇 |
1984年 | 151篇 |
1983年 | 121篇 |
1982年 | 108篇 |
1981年 | 131篇 |
1980年 | 106篇 |
1979年 | 71篇 |
1978年 | 60篇 |
1977年 | 42篇 |
1976年 | 56篇 |
1975年 | 33篇 |
1973年 | 32篇 |
排序方式: 共有10000条查询结果,搜索用时 156 毫秒
71.
Could non-HDL-cholesterol be a better marker of atherogenic dyslipidemia in obstructive sleep apnea?
《Sleep medicine》2021
Background/objectiveObstructive sleep apnea (OSA) is independently associated with dyslipidemia, a surrogate marker of atherosclerosis. Low-density lipoprotein (LDL)-cholesterol is accepted as a major independent risk factor for cardiovascular disease. However, non-high-density lipoprotein (HDL)-cholesterol is a better marker of atherogenic dyslipidemia and recommended as a target of lipid lowering therapy. We aimed to assess the prevalence of atherogenic dyslipidemia, and relationship between OSA severity and serum LDL-cholesterol and non-HDL cholesterol levels in OSA patients.MethodsWe retrospectively evaluated treatment naïve 2361 subjects admitted to the sleep laboratory of a university hospital for polysomnography. All subjects’ lipid profile including total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, and non-HDL-cholesterol were measured.ResultsOut of 2361 patients (mean age 49.6 ± 11.9 years; 68.9% male, apnea-hypopnea index 36.6 ± 28.4/h), 185 (7.8%) had no OSA and 2176 (92.2%) had OSA. Atherogenic dyslipidemia prevalence was high (57–66%) in OSA patients, and especially increased in severe OSA compared to other groups (p < 0.05). Though total and LDL-cholesterol did not differ between those with and without OSA, non-HDL-cholesterol (p = 0.020), and triglycerides (p = 0.001) were higher and HDL-cholesterol levels (p = 0.018) were lower in OSA patients than non-OSA. Non-HDL-cholesterol was significantly correlated with OSA severity (p < 0.001) and hypoxia parameters (p < 0.01), whereas LDL-cholesterol showed no correlation.ConclusionsAtherogenic dyslipidemia is highly prevalent and non-HDL-cholesterol levels are significantly increased, predominantly in severe OSA patients. Non-HDL-cholesterol but not LDL-cholesterol, is significantly correlated with OSA severity and hypoxia parameters. Therefore, it could be better to use non-HDL-cholesterol, which is a guideline recommended target of lipid therapy, as a marker of atherosclerotic cardiovascular risk in OSA patients. 相似文献
72.
Yang Sun Jun-Gong Jin Wei-Yang Mi Hao-Wu Shi-Rong Zhang Qiang Meng Shi-Tao Zhang 《Oncology research》2020,28(6):683-684
Glioma is the most common and lethal malignant intracranial tumor. Long noncoding RNAs (lncRNAs) have
been identified as pivotal regulators in the tumorigenesis of glioma. However, the role of lncRNA urothelial
carcinoma-associated 1 (UCA1) in glioma genesis is still unknown. The purpose of this study was to investigate the underlying function of UCA1 on glioma genesis. The results demonstrated that UCA1 was upregulated
in glioma tissue and indicated a poor prognosis. UCA1 knockdown induced by si-UCA1 significantly suppressed the proliferative, migrative, and invasive activities of glioma cell lines (U87 and U251). Bioinformatics
analysis and luciferase reporter assay verified the complementary binding within UCA1 and miR-122 at the
3¢-UTR. Functional experiments revealed that UCA1 acted as an miR-122 “sponge” to modulate glioma cell
proliferation, migration, and invasion via downregulation of miR-122. Overall, the present study demonstrated
that lncRNA UCA1 acts as an endogenous sponge of miR-122 to promote glioma cell proliferation, migration,
and invasion, which provides a novel insight and therapeutic target in the tumorigenesis of glioma. 相似文献
73.
目的对当归不同炮制品中大肠埃希菌变化进行定量分析。方法建立荧光定量PCR方法,对当归不同炮制品、不同产地、不同收集企业、不同储藏时间的大肠埃希菌进行定量分析。结果不同炮制品中大肠埃希菌数量变化为生当归土炒当归酒当归;在不同产地的当归中以甘肃岷县地区所含的大肠埃希菌的数量最少;与零售企业相比,生产销售企业的当归和酒当归中大肠埃希菌的数量较少;不同储藏时间对当归和酒当归中大肠埃希菌数量有一定影响,随储藏时间的增加,大肠埃希菌的数量也在增加。对部分代表性样品进行平板计数法与荧光定量PCR法比较时发现,平板计数法结果多呈阴性,荧光定量PCR结果均呈阳性。结论所建立的荧光定量PCR法特异性、灵敏度、可靠性以及报告周期均优于平板计数法,可为当归不同炮制品中大肠埃希菌的快速、准确定量检测提供有效手段。 相似文献
74.
Hengzhou Lin Dahui Zuo Jiabin He Tao Ji Jianzhong Wang Taipeng Jiang 《Oncology research》2020,28(6):591-603
The long noncoding RNA WEE2 antisense RNA 1 (WEE2-AS1) plays an oncogenic role in hepatocellular
carcinoma and triple negative breast cancer progression. In this study, we investigated the expression and roles
of WEE2-AS1 in glioblastoma (GBM). Furthermore, the molecular mechanisms behind the oncogenic actions
of WEE2-AS1 in GBM cells were explored in detail. WEE2-AS1 expression was detected using quantitative
real-time polymerase chain reaction. The roles of WEE2-AS1 in GBM cells were evaluated by the cell counting kit-8 assay, flow cytometric analysis, Transwell cell migration and invasion assays, and tumor xenograft
experiments. WEE2-AS1 expression was evidently enhanced in GBM tissues and cell lines compared with
their normal counterparts. An increased level of WEE2-AS1 was correlated with the average tumor diameter,
Karnofsky Performance Scale score, and shorter overall survival among GBM patients. Functionally, depleted
WEE2-AS1 attenuated GBM cell proliferation, migration, and invasion in vitro, promoted cell apoptosis, and
impaired tumor growth in vivo. Mechanistically, WEE2-AS1 functioned as a molecular sponge for microRNA-
520f-3p (miR-520f-3p) and consequently increased specificity protein 1 (SP1) expression in GBM cells. A
series of recovery experiments revealed that the inhibition of miR-520f-3p and upregulation of SP1 could
partially abrogate the influences of WEE2-AS1 downregulation on GBM cells. In conclusion, WEE2-AS1
can adsorb miR-520f-3p to increase endogenous SP1 expression, thereby facilitating the malignancy of GBM.
Therefore, targeting the WEE2-AS1–miR-520f-3p–SP1 pathway might be a promising therapy for the management of GBM in the future. 相似文献
75.
目的探讨麻黄附子细辛汤治疗感染后咳嗽的临床效果。方法选取漯河市郾城区惠生堂门诊部和河南省漯河市第三人民医院呼吸内科于2017年5月—2018年10月诊治的感染后咳嗽患者240例,采用随机数字表法分为两组,对照组患者120例实施常规治疗(退热、吸氧、补液等),观察组患者120例联用麻黄附子细辛汤(紫苏子9 g,射干9 g,地龙9 g,炙麻黄6 g,细辛6 g)治疗,于治疗前后行生化指标(C反应蛋白、白细胞计数、白细胞介素-4)检测和症状(咳嗽、喘息、咳痰、哮鸣音)评分,比较两组患者的症状(咳嗽、喘息、咳痰、哮鸣音)改善时间、临床效果(显效、有效、无效、总有效)、不良反应情况(恶心呕吐、头晕头痛、胃肠道反应)。结果两组治疗后C反应蛋白、白细胞计数、白细胞介素-4、症状评分(咳嗽、喘息、咳痰、哮鸣音)较治疗前显著降低(P<0.05)。观察组治疗后C反应蛋白、白细胞计数、白细胞介素-4、症状评分(咳嗽、喘息、咳痰、哮鸣音)低于对照组(P<0.05)。观察组症状改善时间(咳嗽、喘息、咳痰、哮鸣音)早于对照组(P<0.05)。观察组总有效率(99.2%,119/120)高于对照组(90.0%,108/120)(P<0.05)。结论麻黄附子细辛汤治疗感染后咳嗽的效果显著,可缩短治疗时间并改善病症,值得临床推广使用。 相似文献
76.
77.
78.
目的 探讨长链非编码RNA RAB11B-AS1(lncRNA RAB11B-AS1)在膀胱癌组织中的表达及其与临床病理参数和预后的关系。方法 收集2012年10月—2014年2月于云南省第二人民医院泌尿外科手术切除的83例膀胱癌组织及相应癌旁正常组织。采用qRT-PCR检测lncRNA RAB11B-AS1的表达并分析其与患者临床病理特征的关系,采用Cox回归分析lncRNA RAB11B-AS1表达水平与膀胱癌患者预后的关系。结果 lncRNA RAB11B-AS1在膀胱癌组织中的表达水平低于癌旁正常组织(1.17±0.32 vs 2.09±0.74,t=10.396,P<0.001);膀胱癌癌组织中lncRNA RAB11B-AS1的表达水平与患者TNM分期、组织学分级和淋巴结是否转移有关(P<0.05)。lncRNA RAB11B-AS1高表达患者5年总生存率高于低表达患者(62.22% vs 26.32%,χ2=13.420,P<0.001);多因素Cox回归分析显示,lncRNA RAB11B-AS1低表达是影响膀胱癌患者预后的独立危险因素(HR=1.126,95%CI:1.058~1.200,P<0.001)。结论 lncRNA RAB11B-AS1在膀胱癌组织中低表达,且低表达患者预后较差。 相似文献
79.
80.